Soft Q1 backed by ₹2.5K Cr pipeline, but tenders delay execution

Gross 72.9% confirmed stable; EBITDA 27.3% vs 40.9% YoY; CFO cites Q1'26 had ₹7.65 Cr provision reversals

Q1 delivered ₹141.6 Cr vs ₹178.1 Cr Q4, ₹158.2 Cr Q1'26; new orders only ₹44.6 Cr this quarter

Current ₹1,239 Cr + post-quarter ₹177.5 Cr = ₹1,416 Cr; needs ₹1,084 Cr new inflow in 3Q remaining

CFO: 'No simulator tenders have come out yet.' Post-quarter ₹177.5 Cr is integration order, not new procurement

No anti-drone tenders floated. Ashok admits 'government has not floated any tenders in recent times.'

Prior: 35%; now: 'mid-30s' per CFO. Q1 at 27.3% reflects operating leverage, not structural change, but FY target reduced from guidance.

CFO acknowledged 'no tenders have come out' for simulators or anti-drone. Pipeline of Rs.700-800 Cr simulator orders unproven; no near-term execution confirmed.

C295 flight simulator developed; Air Force now pursuing entry. Positive new channel but earlier stage than Army/Navy, long sales cycle.

Capacity expanded to 300K units; 50% queries from overseas. Revenue currently small; upside if drone segment orders accelerate (currently 'slowed down').

Q1'26 benefited from ₹7.65 Cr provision reversals (~5% margin boost); adjusted real margin was ~35%. This quarter has warranty + R&D charges; sequential margin 27.3% vs 28.6% Q4 is stable underlying run-rate.

₹2,500 Cr after execution. Pipeline 'very healthy'; will convert once government procurement starts.

Yes, ₹800 Cr anti-drone 'post-Sindoor' orders expected; simulator pipeline robust; also tapping North America/EU (TAM ~$10 Bn). But first tenders must come from government.

₹177 Cr order just received (integration); ₹700-800 Cr more in pipeline; government increasing simulator budget; Air Force entry (C295) a crucial step. Gap in orders but starting to come now.

Demonstrated payloads/integration; flying at 300 km/h+ comfortably; still testing physics limits with full payload. On track structurally but timing pushing beyond FY28.

Very difficult market; pursuing FOCI, ITAR clearances now; aligning with prime vendors; modest ambition: $100 Mn by year 3. Long-term game; no big news expected 1-2 years.

Simulators & anti-drone mature; sizable inflow past months. Robotics taking time (2-3 yrs). Autonomous vehicles future investment. Demand-limited, not supply-limited; no tenders out yet. Once tenders come, orders 'very, very fast.'

Demand-limited. No tenders have come out. Government has not floated tenders recently. Issue is government, not Zen. When they float, we'll bid and win fast (few months to finalize).

This ₹177 Cr is integration only, not new procurement. TAM is 2,400+ simulators (4,000 tanks × 6 operators × 200 training hours). This order is 'very, very small part.' 10-year lifecycle; AMC from year 3 onwards drives recurring revenue.

Government in fast-track mode (12-month cycle) for urgent procurement; regular procurement still multi-year. Getting more FTP orders but large deals still via regular channels.

Won't predict precisely; but ₹700-800 Cr simulators incoming; anti-drone will be 'thousands of Crores' later. 'Very large market'; multiple players will benefit.

Q1 came in ₹141.6 Cr as planned low-revenue quarter. Order book ₹1.2K Cr supports execution but tendering delays a risk.

Needs ₹1.1K Cr new inflow in 3 quarters; ₹177.5 Cr post-quarter is integration order, not new production. Simulator & anti-drone tenders have not been floated.

Multi-year guidance intact but near-term (FY27) execution now flagged as demand-dependent; no tenders floated so far.

Q1 at 27.3% explained by fixed-cost leverage on low Q1 revenue. As revenue scales Q2-Q3, margin recovery expected.

Q1 at ~24.3% (reported); adjusted ~26% ex-exceptional loss. Consistent with long-term 25% if revenue grows as guided.

Incremental R&D ₹4.25 Cr this quarter. 2-3 year horizon for maturity. Management signaled 'heavy investment' in future capabilities.

CFO explicitly stated 'no tenders have come out' for simulators or anti-drone. ₹2.5K Cr FY27 order book target and ₹4K Cr cumulative guidance both depend on multi-quarter tendering. Extended delay could slip orders to FY28.

Q1 new orders only ₹44.6 Cr vs ₹141.6 Cr execution creates high dependency on backlog conversion. ₹177.5 Cr post-quarter is integration (non-revenue increasing). If large orders (₹700-800 Cr simulator) don't materialize in expected quarters, revenue could miss.

CFO's entire margin recovery thesis (27.3% → 'mid-30s') rests on revenue scaling Q2-Q3 to absorb fixed costs. If orders delay and Q2-Q3 revenue doesn't materialize, fixed-cost burden remains and margins compress further.

Robotics (Vrishabh), autonomous vehicles, laser weapons, interceptor drones all 2-3 year timeline to commercialization. Early-stage R&D carries execution/technology obsolescence risk. Heavy capex with no near-term revenue.

WC cycle 257 days (elevated from year-end) due to supplier advances + inventory buildup for order execution. If orders delay, this inventory becomes stranded and cash tied up.